{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:58:42Z","timestamp":1788559122841,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00428-021-03154-x","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T06:02:38Z","timestamp":1626674558000},"page":"443-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study"],"prefix":"10.1007","volume":"479","author":[{"given":"Meng","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhou","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-114X","authenticated-orcid":false,"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"3154_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7\u201334","journal-title":"CA Cancer J Clin"},{"key":"3154_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-019-05295-9","volume":"177","author":"M Krystel-Whittemore","year":"2019","unstructured":"Krystel-Whittemore M, Xu J, Brogi E et al (2019) Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy. Breast Cancer Res Treat 177:61\u201366","journal-title":"Breast Cancer Res Treat"},{"key":"3154_CR3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1200\/JCO.19.01455","volume":"38","author":"L Fehrenbacher","year":"2020","unstructured":"Fehrenbacher L, Cecchini RS, Geyer CE et al (2020) NSABP B-47\/NRG oncology phase III randomized trial comparing adjuvant chemotherapy with or without trastuzumab in high-risk invasive breast cancer negative for HER2 by FISH and with IHC 1+ or 2. J Clin Oncol 38:444\u2013453","journal-title":"J Clin Oncol"},{"key":"3154_CR4","doi-asserted-by":"crossref","unstructured":"Wolff AC, Hammond MEH, Allison KH et al (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update. J Clin Oncol 36:2105\u20132122","DOI":"10.1200\/JCO.2018.77.8738"},{"key":"3154_CR5","doi-asserted-by":"crossref","unstructured":"Wolff AC, Hammond ME, Hicks DG, et al (2015) Reply to E.A. Rakha et al.  J Clin Oncol 33:1302\u20131304","DOI":"10.1200\/JCO.2014.59.7559"},{"key":"3154_CR6","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31:3997\u20134013","journal-title":"J Clin Oncol"},{"key":"3154_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41379-020-0461-z","volume":"33","author":"S Zhou","year":"2020","unstructured":"Zhou S, Yang F, Bai Q et al (2020) Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma. Mod Pathol 33:1275\u20131286","journal-title":"Mod Pathol"},{"key":"3154_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/modpathol.2018.28","volume":"31","author":"RL Stewart","year":"2018","unstructured":"Stewart RL, Gulbahce EH, Geiersbach KB et al (2018) Reply to Commentary on \u2018HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features.\u2019 Mod Pathol 31:686","journal-title":"Mod Pathol"},{"key":"3154_CR9","doi-asserted-by":"crossref","unstructured":"Marchio C, Annaratone L, Marques A, et al (2020) Evolving concepts in HER2 evaluation in breast cancer: heterogeneity, HER2-low carcinomas and beyond. Semin Cancer Biol 72:123\u2013135","DOI":"10.1016\/j.semcancer.2020.02.016"},{"key":"3154_CR10","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1200\/JCO.19.02318","volume":"38","author":"S Modi","year":"2020","unstructured":"Modi S, Park H, Murthy RK et al (2020) Antitumor activity and safety of trastuzumab deruxtecan in patients with HER2-low-expressing advanced breast cancer: results from a phase Ib study. J Clin Oncol 38:1887\u20131896","journal-title":"J Clin Oncol"},{"key":"3154_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00428-015-1868-7","volume":"468","author":"HO Helin","year":"2016","unstructured":"Helin HO, Tuominen VJ, Ylinen O et al (2016) Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry. Virchows Arch 468:191\u2013198","journal-title":"Virchows Arch"},{"key":"3154_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/his.13333","volume":"72","author":"T Qaiser","year":"2018","unstructured":"Qaiser T, Mukherjee A, Reddy Pb C et al (2018) HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues. Histopathology 72:227\u2013238","journal-title":"Histopathology"},{"key":"3154_CR13","first-page":"917","volume":"74","author":"T Koopman","year":"2019","unstructured":"Koopman T, Buikema HJ, Hollema H et al (2019) What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms Histopathology 74:917\u2013924","journal-title":"A study with multiple platforms Histopathology"},{"key":"3154_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/labinvest.2017.82","volume":"97","author":"M Barnes","year":"2017","unstructured":"Barnes M, Srinivas C, Bai I et al (2017) Whole tumor section quantitative image analysis maximizes between-pathologists\u2019 reproducibility for clinical immunohistochemistry-based biomarkers. Lab invest 97:1508\u20131515","journal-title":"Lab invest"},{"key":"3154_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1309\/Y73U8X72B68TMGH5","volume":"121","author":"K Bloom","year":"2004","unstructured":"Bloom K, Harrington D (2004) Enhanced accuracy and reliability of HER-2\/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol 121:620\u2013630","journal-title":"Am J Clin Pathol"},{"key":"3154_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.5858\/arpa.2018-0378-CP","volume":"143","author":"MM Bui","year":"2019","unstructured":"Bui MM, Riben MW, Allison KH et al (2019) Quantitative image analysis of human epidermal growth factor receptor 2 immunohistochemistry for breast cancer: guideline from the College of American Pathologists. Arch Pathol Lab Med 143:1180\u20131195","journal-title":"Arch Pathol Lab Med"},{"key":"3154_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/jpi.jpi_52_19","volume":"11","author":"R Hartage","year":"2020","unstructured":"Hartage R, Li AC, Hammond S et al (2020) A validation study of human epidermal growth factor receptor 2 immunohistochemistry digital imaging analysis and its correlation with human epidermal growth factor receptor 2 fluorescence in situ hybridization results in breast carcinoma. J Pathol Inform 11:2","journal-title":"J Pathol Inform"},{"key":"3154_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.5858\/arpa.2014-0127-OA","volume":"139","author":"VR Sarode","year":"2015","unstructured":"Sarode VR, Xiang QD, Christie A et al (2015) Evaluation of HER2\/neu status by immunohistochemistry using computer-based image analysis and correlation with gene amplification by fluorescence in situ hybridization assay: a 10-year experience and impact of test standardization on concordance rate. Arch Pathol Lab Med 139:922\u2013928","journal-title":"Arch Pathol Lab Med"},{"key":"3154_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/PAS.0000000000000375","volume":"39","author":"J Dennis","year":"2015","unstructured":"Dennis J, Parsa R, Chau D et al (2015) Quantification of human epidermal growth factor receptor 2 immunohistochemistry using the Ventana Image Analysis System: correlation with gene amplification by fluorescence in situ hybridization: the importance of instrument validation for achieving high (>95%) concordance rate. Am J Surg Pathol 39:624\u2013631","journal-title":"Am J Surg Pathol"},{"key":"3154_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10549-020-05546-0","volume":"180","author":"AC Li","year":"2020","unstructured":"Li AC, Zhao J, Zhao C et al (2020) Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma. Breast Cancer Res Treat 180:321\u2013329","journal-title":"Breast Cancer Res Treat"},{"key":"3154_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.media.2019.03.007","volume":"54","author":"C Payer","year":"2019","unstructured":"Payer C, Stern D, Bischof H, Urschler M (2019) Integrating spatial configuration into heatmap regression based CNNs for landmark localization. Med Image Anal 54:207\u2013219","journal-title":"Med Image Anal"},{"key":"3154_CR22","doi-asserted-by":"publisher","first-page":"101621","DOI":"10.1016\/j.media.2019.101621","volume":"60","author":"J Zhang","year":"2020","unstructured":"Zhang J, Liu M, Wang L et al (2020) Context-guided fully convolutional networks for joint craniomaxillofacial bone segmentation and landmark digitization. Medical image analysis 60:101621","journal-title":"Medical image analysis"},{"key":"3154_CR23","doi-asserted-by":"crossref","unstructured":"Chaurasia A, Culurciello E (2018) LinkNet: exploiting encoder representations for efficient semantic segmentation. IEEE Int Conf Vis Commun 2017:1\u20134","DOI":"10.1109\/VCIP.2017.8305148"},{"key":"3154_CR24","unstructured":"Ruifrok AC, Johnston D (2001) Quantification of histochemical staining by color deconvolution. Anal Quat Cytol Histol 23(4):291\u2013299"},{"issue":"3","key":"3154_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1145\/357994.358023","volume":"27","author":"TY Zhang","year":"1984","unstructured":"Zhang TY, Suen CY (1984) A fast parallel algorithm for thinning digital patterns. Comm Acm 27(3):236\u2013239","journal-title":"Comm Acm"},{"key":"3154_CR26","unstructured":"Zhang J, Tian K, Dong P, et al (2020) Microscope based HER2 scoring system. arXiv preprint arXiv:2009.06816"},{"key":"3154_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-011-1514-2","volume":"132","author":"A Br\u00fcgmann","year":"2011","unstructured":"Br\u00fcgmann A, Eld M, Lelkaitis G et al (2011) Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains. Breast Cancer Res Treat 132:41\u201349","journal-title":"Breast Cancer Res Treat"},{"key":"3154_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10549-015-3475-3","volume":"152","author":"H Holten-Rossing","year":"2015","unstructured":"Holten-Rossing H, Moller Talman ML, Kristensson M et al (2015) Optimizing HER2 assessment in breast cancer: application of automated image analysis. Breast Cancer Res Treat 152:367\u2013375","journal-title":"Breast Cancer Res Treat"},{"key":"3154_CR29","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1109\/TMI.2019.2907049","volume":"38","author":"T Qaiser","year":"2019","unstructured":"Qaiser T, Rajpoot NM (2019) Learning where to see: a novel attention model for automated immunohistochemical scoring. IEEE Trans Med Imaging 38:2620\u20132631","journal-title":"IEEE Trans Med Imaging"},{"key":"3154_CR30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-2559.2011.04142.x","volume":"60","author":"VJ Tuominen","year":"2012","unstructured":"Tuominen VJ, Tolonen TT, Isola J (2012) ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry. Histopathology 60:758\u2013767","journal-title":"Histopathology"},{"key":"3154_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5858\/135.2.233","volume":"135","author":"MA Gavrielides","year":"2011","unstructured":"Gavrielides MA, Gallas BD, Lenz P et al (2011) Observer variability in the interpretation of HER2\/neu immunohistochemical expression with unaided and computer-aided digital microscopy. Arch Pathol Lab Med 135:233\u2013242","journal-title":"Arch Pathol Lab Med"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03154-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03154-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03154-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T01:26:40Z","timestamp":1631928400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03154-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3154"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03154-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}